On May 12, 2023, Paratek Pharmaceuticals, Inc announced that it has filed a preliminary proxy statement soliciting proxies and urged the shareholders to vote for its board nominees: Minnie Baylor-Henry, Michael F. Bigham and Robert S. Radie at the Company’s annual general meeting scheduled to be held on July 6, 2023.